GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » EV-to-Revenue

Hans Biomed (XKRX:042520) EV-to-Revenue : 2.52 (As of May. 27, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hans Biomed's enterprise value is ₩197,435 Mil. Hans Biomed's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩78,321 Mil. Therefore, Hans Biomed's EV-to-Revenue for today is 2.52.

The historical rank and industry rank for Hans Biomed's EV-to-Revenue or its related term are showing as below:

XKRX:042520' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.63   Med: 4.66   Max: 26.1
Current: 2.52

During the past 13 years, the highest EV-to-Revenue of Hans Biomed was 26.10. The lowest was 1.63. And the median was 4.66.

XKRX:042520's EV-to-Revenue is ranked better than
58.72% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.26 vs XKRX:042520: 2.52

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Hans Biomed's stock price is ₩13550.00. Hans Biomed's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩6,946.65. Therefore, Hans Biomed's PS Ratio for today is 1.95.


Hans Biomed EV-to-Revenue Historical Data

The historical data trend for Hans Biomed's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed EV-to-Revenue Chart

Hans Biomed Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.47 3.09 3.30 1.84 3.11

Hans Biomed Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.84 2.61 3.43 3.11 2.72

Competitive Comparison of Hans Biomed's EV-to-Revenue

For the Medical Devices subindustry, Hans Biomed's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hans Biomed's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hans Biomed's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hans Biomed's EV-to-Revenue falls into.



Hans Biomed EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hans Biomed's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=197435.039/78321.151
=2.52

Hans Biomed's current Enterprise Value is ₩197,435 Mil.
Hans Biomed's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩78,321 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hans Biomed  (XKRX:042520) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hans Biomed's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=13550.00/6946.645
=1.95

Hans Biomed's share price for today is ₩13550.00.
Hans Biomed's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,946.65.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hans Biomed EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hans Biomed's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hans Biomed (XKRX:042520) Business Description

Traded in Other Exchanges
N/A
Address
8th Floor SK Building 16-4, Sungsu 1 ga Dong, Sungdong-gu, Seoul, KOR
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures artificial skin for a skin graft, various bones mainly for dental implants and joints and medical silicone.

Hans Biomed (XKRX:042520) Headlines

No Headlines